ReviewNature and timing of post-approval manufacturing changes of tumour necrosis factor α inhibitor products: A 20-year follow-up study of originators and biosimilars
Under a Creative Commons license
open access
Graphical abstract
Keywords
Biopharmaceuticals
Tumour necrosis factor alpha inhibitors
Reference products
Originators
Biosimilars
Comparability
Manufacturing changes
Quality attributes
Consistency
Cited by (0)
© 2022 The Authors. Published by Elsevier B.V.